Our results demonstrated that DAXX is negatively correlated with tumor metastasis and that DAXX is down-regulated at the metastatic site compared to the primary lesion, implying that DAXX may act as a metastasis suppressor in CRC. The gene discussed is DAXX; the disease is colorectal carcinoma.